Founder populations and their uses for breast cancer genetics.

Abstract excerpt

Numerous founder mutations have been reported in BRCA1 and BRCA2. For genetic screening of a population with a founder mutation, testing can be targeted to the mutation, allowing for a more rapid and less expensive test. In addition, more precise estimates of the prior probability of carrying a mutation and of the likelihood of a mutation carrier developing cancer should be possible. For a given founder mutation...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to BRCA2 Protein
• Share to Breast Neoplasms
• Share to Genes, BRCA1